BIOMAT Database Logo BIOMAT Database Logo

In vitro and in vivo antibacterial activities of broad spectrum quinolones against clinical bacterial isolates. 1995

T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
Department of Microbiology, Toho University School of Medicine, Tokyo, Japan.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D042462 4-Quinolones QUINOLONES containing a 4-oxo (a carbonyl in the para position to the nitrogen). They inhibit the A subunit of DNA GYRASE and are used as antimicrobials. Second generation 4-quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine at the 6-position. 4-Oxoquinoline,4-Quinolinone,4-Quinolone,4-Oxoquinolines,4-Quinolinones,4 Oxoquinoline,4 Oxoquinolines,4 Quinolinone,4 Quinolinones,4 Quinolone,4 Quinolones
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
[In vitro antibacterial activities of broad spectrum quinolones against clinical bacterial isolates].
January 1994, The Japanese journal of antibiotics,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
[Antibacterial activities of new quinolones against fresh clinical isolates].
October 1994, The Japanese journal of antibiotics,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China.
June 2000, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
[In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
December 1975, The Japanese journal of antibiotics,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
June 2001, Antimicrobial agents and chemotherapy,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
Broad-spectrum in vitro antibacterial activities of clay minerals against antibiotic-susceptible and antibiotic-resistant bacterial pathogens.
February 2008, The Journal of antimicrobial chemotherapy,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
[In vitro antibacterial activities of carbapenems against clinical isolates].
November 1999, The Japanese journal of antibiotics,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem.
December 1997, Antimicrobial agents and chemotherapy,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
October 1978, Antimicrobial agents and chemotherapy,
T Matsumoto, and K Tateda, and Y Ishii, and A Ohno, and S Miyazaki, and K Yamaguchi
In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin.
February 1993, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!